Culture

A NEAT reduction of complex neuronal models accelerates brain research

image: Complex to abstract, the fascinating tree structure of dendrites can now be modelled at many scales.

Image: 
© eLife

Neurons, the fundamental units of the brain, are complex computers by themselves. They receive input signals on a tree-like structure - the dendrite. This structure does more than simply collect the input signals: it integrates and compares them to find those special combinations that are important for the neurons' role in the brain. Moreover, the dendrites of neurons come in a variety of shapes and forms, indicating that distinct neurons may have separate roles in the brain.

A simple yet faithful model

In neuroscience, there has historically been a tradeoff between a model's faithfulness to the underlying biological neuron and its complexity. Neuroscientists have constructed detailed computational models of many different types of dendrites. These models mimic the behavior of real dendrites to a high degree of accuracy. The tradeoff, however, is that such models are very complex. Thus, it is hard to exhaustively characterize all possible responses of such models and to simulate them on a computer. Even the most powerful computers can only simulate a small fraction of the neurons in any given brain area.

Researchers from the Department of Physiology at the University of Bern have long sought to understand the role of dendrites in computations carried out by the brain. On the one hand, they have constructed detailed models of dendrites from experimental measurements, and on the other hand they have constructed neural network models with highly abstract dendrites to learn computations such as object recognition. A new study set out to find a computational method to make highly detailed models of neurons simpler, while retaining a high degree of faithfulness. This work emerged from the collaboration between experimental and computational neuroscientists from the research groups of Prof. Thomas Nevian and Prof. Walter Senn, and was led by Dr Willem Wybo. "We wanted the method to be flexible, so that it could be applied to all types of dendrites. We also wanted it to be accurate, so that it could faithfully capture the most important functions of any given dendrite. With these simpler models, neural responses can more easily be characterized and simulation of large networks of neurons with dendrites can be conducted," Dr Wybo explains.

This new approach exploits an elegant mathematical relation between the responses of detailed dendrite models and of simplified dendrite models. Due to this mathematical relation, the objective that is optimized is linear in the parameters of the simplified model. "This crucial observation allowed us to use the well-known linear least squares method to find the optimized parameters. This method is very efficient compared to methods that use non-linear parameter searches, but also achieves a high degree of accuracy," says Prof. Senn.

Tools available for AI applications

The main result of the work is the methodology itself: a flexible yet accurate way to construct reduced neuron models from experimental data and morphological reconstructions. "Our methodology shatters the perceived tradeoff between faithfulness and complexity, by showing that extremely simplified models can still capture much of the important response properties of real biological neurons," Prof. Senn explains. "Which also provides insight into 'the essential dendrite', the simplest possible dendrite model that still captures all possible responses of the real dendrite from which it is derived," Dr Wybo adds.

Thus, in specific situations, hard bounds can be established on how much a dendrite can be simplified, while retaining its important response properties. "Furthermore, our methodology greatly simplifies deriving neuron models directly from experimental data," Prof. Senn highlights, who is also a member of the steering committe of the Center for Artifical Intelligence (CAIM) of the University of Bern. The methodology has been compiled into NEAT (NEural Analysis Toolkit) - an open-source software toolbox that automatizes the simplification process. NEAT is publicly available on GitHub.

The neurons used currently in AI applications are exceedingly simplistic compared to their biological counterparts, as they don't include dendrites at all. Neuroscientists believe that including dendrite-like operations in artificial neural networks will lead to the next leap in AI technology. By enabling the inclusion of very simple, but very accurate dendrite models in neural networks, this new approach and toolkit provide an important step towards that goal.

This work was supported by the Human Brain Project, by the Swiss National Science foundation and by the European Research Council.

Credit: 
University of Bern

Vaccine delivered via skin could help in fight against respiratory diseases

Among infectious diseases that have caused pandemics and epidemics, smallpox stands out as a success story. Smallpox vaccination led to the disease's eradication in the twentieth century. Until very recently, smallpox vaccine was delivered using a technique known as skin scarification (s.s.), in which the skin is repeatedly scratched with a needle before a solution of the vaccine is applied. Almost all other vaccines today are delivered via intramuscular injection, with a needle going directly into the muscle, or through subcutaneous injection to the layer of tissue beneath the skin. But Thomas Kupper, MD, chair of the Department of Dermatology, and colleagues, had reason to suspect that vaccines delivered by skin scarification may offer better protection against respiratory diseases. In a study published in Npj vaccines, Kupper and co-authors present results from preclinical studies suggesting skin scarification may help generate lung T cells and provide protection against infectious diseases, with implications for prevention of COVID-19.

"We have known for years that this technique was a good way to generate T cells that would home to the skin, but our study shows that skin scarification is also an effective way to generate T cells that home to the lungs," said Kupper. "Vaccine development today is focused on selecting the best antigen(s) for T cells and B cells. But for a vaccine to work to its full potential, it also needs to direct T cells to where they are needed most. For respiratory pathogens, that means getting T cells to the lungs."

Historically, smallpox vaccines used live vaccinia virus (VACV). More recently, the Food and Drug Administration has approved the use of modified vaccinia Ankara (MVA), a modern alternative that lacks about 10 percent of the parent genome and cannot replicate in human cells, thus avoiding the serious side effects seen with VACV. MVA, as a smallpox vaccine, is injected subcutaneously.

Kupper and colleagues set out to determine if the skin scarification route of immunization with MVA could provoke a more effective T cell response than other routes of immunization. The team inoculated mice using either skin scarification, intramuscular, subcutaneous, or intradermal injection. Skin scarification generated more T cells, produced greater numbers of lung-specific T cells and provided superior protection against lethal viral doses than the others.

"We used to think that lung-homing T cells could only be generated by direct lung infection, but here we find overlap between T cells appearing after lung infection and T cells generated through skin scarification," said Kupper.

The authors note that their work is preclinical -- until clinical trials are conducted in humans, it's unknown if the phenomenon seen in the mouse model can be replicated in people. But the work has spurred the Kupper lab to explore the potential for using the MVA vector and skin scarification technique to develop more powerful -- and, potentially universal -- vaccines against other infectious illnesses such as influenza and coronaviruses.

"We have known for a while that you can program T cells to go where you want them to go in the body -- if you want protective T cells in the lungs, this is one way to achieve that. It is a serendipitous finding, but it seems to work very well," said Kupper.

Credit: 
Brigham and Women's Hospital

Scientists jump-start two people's brains after coma

image: Martin Monti, UCLA professor of psychology and neurosurgery

Image: 
Ivy Reynolds

In 2016, a team led by UCLA's Martin Monti reported that a 25-year-old man recovering from a coma had made remarkable progress following a treatment to jump-start his brain using ultrasound.

Wired U.K. called the news one of the best things that happened in 2016. At the time, Monti acknowledged that although he was encouraged by the outcome, it was possible the scientists had gotten a little lucky.

Now, Monti and colleagues report that two more patients with severe brain injuries -- both had been in what scientists call a long-term "minimally conscious state" -- have made impressive progress thanks to the same technique. The results are published online in the journal Brain Stimulation.

"I consider this new result much more significant because these chronic patients were much less likely to recover spontaneously than the acute patient we treated in 2016 -- and any recovery typically occurs slowly over several months and more typically years, not over days and weeks, as we show," said Monti, a UCLA professor of professor of psychology and neurosurgery and co-senior author of the new paper. "It's very unlikely that our findings are simply due to spontaneous recovery."

The paper notes that, of three people who received the treatment, one -- a 58-year-old man who had been in a car accident five-and-a-half years prior to treatment and was minimally conscious -- did not benefit. However, the other two did.

One is a 56-year-old man who had suffered a stroke and had been in a minimally conscious state, unable to communicate, for more than 14 months. After the first of two treatments, he demonstrated, for the first time, the ability to consistently respond to two distinct commands -- the ability to drop or grasp a ball, and the ability to look toward separate photographs of two of his relatives when their names were mentioned.

He also could nod or shake his head to indicate "yes" or "no" when asked questions such as "Is X your name?" and "Is Y your wife's name?"

Small but significant improvement

In the days following the second treatment, he also demonstrated, for the first time since the stroke, the ability to use a pen on paper and to raise a bottle to his mouth, as well as to communicate and answer questions.

"Importantly," Monti said, "these behaviors are diagnostic markers of emergence from a disorder of consciousness."

The other patient who improved is a 50-year-old woman who had been in even less of a conscious state for more than two-and-a-half years following cardiac arrest. In the days after the first treatment, she was able, for the first time in years, according to her family, to recognize a pencil, a comb and other objects.

Both patients showed the ability to understand speech.

"What is remarkable is that both exhibited meaningful responses within just a few days of the intervention," Monti said. "This is what we hoped for, but it is stunning to see it with your own eyes. Seeing two of our three patients who had been in a chronic condition improve very significantly within days of the treatment is an extremely promising result."

The changes the researchers saw are small, but Monti said even the smallest form of communication means a way to reconnect. One powerful moment during the study was when the wife of the 56-year-old man showed him photos and asked whether he recognized who he saw.

"She said to us, 'This is the first conversation I had with him since the accident,'" Monti said. "For these patients, the smallest step can be very meaningful -- for them and their families. To them it means the world."

Using acoustic energy

The scientists used a technique called low-intensity focused ultrasound, which uses sonic stimulation to excite the neurons in the thalamus, an egg-shaped structure that serves as the brain's central hub for processing. After a coma, thalamus function is typically weakened, Monti said.

Doctors use a device about the size of a saucer creates a small sphere of acoustic energy they can aim at different brain regions to excite brain tissue. The researchers placed the device by the side of each patient's head and activated it 10 times for 30 seconds each in a 10-minute period. Each patient underwent two sessions, one week apart.

Monti hopes to eventually translate the technology into an inexpensive, portable device so the treatment could be delivered not only at state-of-the-art medical centers, but also at patients' homes, to help "wake up" patients from a minimally conscious or vegetative state.

The treatment appears to be well tolerated; the researchers saw no changes to the patients' blood pressure, heart rate or blood oxygen levels, and no other adverse events. Monti said the device is safe because it emits only a small amount of energy, less than a conventional Doppler ultrasound.

While the scientists are excited by the results, they emphasize that the technique is still experimental and likely will not be available to the public for at least a few years. For now, there is little that can be done to help patients recover from a severe brain injury that results in either a chronic vegetative state or a minimally conscious state, Monti said.

Monti said his team is planning additional studies to learn exactly how thalamic ultrasound modifies brain function; he hopes to start those clinical trials once the researchers and patients are assured of being safe from COVID-19.

The study's lead author is Josh Cain, a UCLA graduate student in psychology, and a co-senior author is Caroline Schnakers, a former UCLA researcher who is now assistant director of research at Casa Colina Hospital and Centers for Healthcare in Pomona, California. The work was funded by the Tiny Blue Dot Foundation and the Dana Foundation.

Understanding the terminology

People in a coma appear as if they are under general anesthesia; their eyes are closed, and they do not wake up even if someone tries to rouse them. Some people do eventually recover from a coma and regain significant cognitive function. Others move into a puzzling condition called a vegetative state in which they are awake -- that is, their eyes open and close as if they are waking up and falling asleep -- but they show no signs of consciousness.

A minimally conscious state is a condition in which people are awake (they wake up and fall asleep periodically) but show subtle signs that they are conscious -- for example, the ability to blink their eyes in response to a command.

Credit: 
University of California - Los Angeles

Forests with diverse tree sizes and small clearings hinder wildland fire growth

image: Wildfires are becoming more prolific and devastating. A Los Alamos study reveals dynamics that help practitioners predict and prevent fire.

Image: 
Courtesy of National Park Service

LOS ALAMOS, N.M., January 27, 2021--A new 3D analysis shows that wildland fires flare up in forests populated by similar-sized trees or checkerboarded by large clearings and slow down where trees are more varied. The research can help fire managers better understand the physics and dynamics of fire to improve fire-behavior forecasts.

"We knew fuel arrangement affected fire but we didn't know how," said Adam Atchley, lead author on a Los Alamos National Laboratory-led study published today in the International Journal of Wildland Fire. "Traditional models that represent simplified fuel structures can't account for complex wind and varied fire response to actual forest conditions. Our study incorporated a varied, 3D forest and wind behavior. Adding diverse tree sizes and shapes slowed fire quite a bit, as did adding small gaps between trees. By examining the physics of fire-fuel behavior, we are able to see fundamentally how forest structure affects behavior."

The study for the first time links generalized forest characteristics that can be easily observed by remote sensing and modeled by machine learning to provide insight into fire behavior, even in large forested areas.

Understanding how wildland fire behaves is necessary to curb its spread, and also to plan safe, effective prescribed burns. However, data is limited, and most studies are too simplistic to accurately predict fire behavior. To predict how fire will move through a forest, it is necessary to first paint an accurate picture of a typical forest's diversity with varying density, shapes, and sizes of trees. But this is computationally expensive, so most studies target homogenous forests that rarely occur in nature.

Using its award-winning model, FIRETEC, on high-performance computers at Los Alamos, the team ran 101 simulations with U.S. Forest Service data for Arizona pine forests to realistically represent the variability of forests. The simulations coupled fire and atmospheric factors--such as wind moving through trees--at fine scales to provide a 3D view of how fire, wind, and vegetation interact.

To understand how the forest structure affects fire behavior, Atchley and colleagues repeated simulations with minor changes in the forest structure, which they made by moving trees and randomizing tree shapes. Small changes had monumental impact in fire behavior. However, despite highly variable fire behavior, observable forest characteristics, such as tree diversity and the size of a stand of trees or a clearing, also substantially control how fire spreads.

Results show that the more detailed and varied simulated forest decreases the forward spread of fire spread due to a combination of fuel discontinuities and increases fine-scale turbulent wind structures. On the other hand, large clearings can increase fire spread.

Credit: 
DOE/Los Alamos National Laboratory

Working memory can help tailor educational development

image: Nelson Cowan is a Curators Distinguished Professor in the Department of Psychological Sciences at the University of Missouri

Image: 
University of Missouri

Imagine a 7-year-old and a college student both take a break from their virtual classes to get a drink of water. When they return, the 7-year-old has difficulty restarting the assignment, while the college student resumes working as if the break never occurred. Nelson Cowan, an expert in working memory at the University of Missouri, believes understanding this developmental age difference can help younger children and their parents to better adjust to a virtual learning environment during the COVID-19 pandemic.

"By understanding this developmental difference, then we can work to provide a little more structure for younger children in online settings, such as helping them organize their homework," said Cowan, a Curators Distinguished Professor in the Department of Psychological Sciences. "At school, teachers can provide more of that structure, but in a virtual environment, parents may also have to take on more of that responsibility. For parents who have younger children that are somewhat resistant to their actions, this might be difficult to do, however it needs to be made clear to children that their parents are assisting their teacher, rather than being the primary educational figure."

Kendall Holzum can relate. During the COVID-19 pandemic, the 7-year-old girl has been going to school online instead of in person.

"Sometimes it's hard to remember to go back and do your homework after you get off your Zoom call," Holzum said. "My parents have to help me a lot to remember to do my assignments. Homework is the hardest to follow directions on because your teacher isn't there to always help you."

Cowan, who has been interested in how the human brain works since he was a young child, suggests this insight can be a first step toward helping educators determine how to tailor a child's individual learning experience to their appropriate developmental level.

"Now, the challenge will be to understand how to adapt educational materials and work materials to be appropriate for each individual's developmental level in an online setting and perhaps try to teach children to be more proactive in their thinking," Cowan said. "I'm hoping this is a first step toward that notion and encourages people who do research in the classroom, or now in the virtual classroom, to consider the role of proactive behavior as an overall life skill and how to accommodate various levels of learning to meet that life goal."

A total of 180 people participated in the study by Cowan and his colleagues. Participants were split among three different age groups -- children ages 6-8, ages 10-14 and college students. Each age group was asked to remember a display of colored spots. Then, they were interrupted by a second, unexpected and more urgent task -- quickly pressing a button when a signal is heard or seen. Upon completion of the second task, they were asked to return to the first task and decide if a color came from the display. Cowan said more often, the younger children simply forgot to remember the colors they were supposed to recall after working on the second task. He said this study provides a clear example of the limits of working memory in younger children.

"In general, working memory is limited," Cowan said. "As the amount of things a person is trying to remember at one time increases, less memory is available to help remember a task, or what a person is supposed to be doing. An example of the difference between an adult and a child is when both try to catch a ball while carrying dishes. The child would be more likely to drop the dishes, while the adult remembers to also hold onto the dishes at the same time. Virtual school has created a whole new environment, and this study provides us with a first step in how we must help children adjust as some parts of virtual schooling are very likely to be here for a long time."

Credit: 
University of Missouri-Columbia

Lung-MAP translational discoveries shared at 2020 World Conference on Lung Cancer

WASHINGTON, DC - Investigators leading the Lung Cancer Master Protocol, or Lung-MAP trial, will present findings from three translational medicine studies at the 2020 World Conference on Lung Cancer, to be held online January 28-31, 2021.

The presentations will mark the first time that investigators share translational medicine insights from Lung-MAP, the first large-scale precision medicine trial in lung cancer backed by the National Cancer Institute (NCI), part of the National Institutes of Health, and the first major NCI trial to test multiple treatments, simultaneously, under one "umbrella" design. Since it launched in June 2014, the trial has tested 12 new lung cancer drugs. Lung-MAP has also amassed a scientifically valuable cache of data and biospecimens from 3,021 patients.

"Lung-MAP now has one of the largest collections of data and biospecimens ever gathered for lung cancer," said Roy Herbst, MD, PhD, a Yale University professor and the Lung-MAP study chair. "It's gratifying to see this asset put to use to improve our understanding of lung cancer - and find better ways to treat it."

Results from the Lung-MAP studies will be shared at the 2020 World Conference on Lung Cancer, or WCLC. Organized annually by the International Association for the Study of Lung Cancer, the conference was planned for Singapore but will be held virtually due to the COVID-19 pandemic. The WCLC is the world's largest international gathering of clinicians, researchers, and scientists in the field of lung cancer and thoracic oncology.

Here are summaries of the Lung-MAP presentations to be delivered:

Fred Hirsch, MD, PhD (Tisch Cancer Institute, Mount Sinai) will give an oral presentation on work that examined tumor mutational burden - or TMB - and related biomarkers to evaluate whether there were any connections to clinical outcomes of immunotherapy. Using next-generation sequencing data on tissue from 320 patients enrolled in two sub-studies of patients receiving immunotherapy for the first time under the original Lung-MAP master protocol, Hirsch and colleagues evaluated associations between TMB and how long patients lived, and how long they remained cancer-free. They found that higher TMB was significantly associated with better survival rates, and longer periods of time before patients' lung cancer returned or spread. However, expression of the PD-L1 gene - a "brake" on the immune system that contributes to cancer growth - was not associated with better outcomes. "We found TMB to be a good predictor of outcomes to immunotherapy, which operates independently of PD-L1 expression," Hirsch said. "What was interesting in the findings is the emergence of the idea that when we look at TMB to predict outcomes, we should assess TMB as a continuous variable rather than using fixed cut-off values." Hirsch presents this work January 29 (Abstract OA01.04).

David Kozono, MD, PhD (Dana Farber Cancer Institute) will give a mini-oral presentation of an analysis of next-generation sequencing data gathered from the original Lung-MAP master protocol S1400. Patients on that study had tumor tissue samples genetically tested with Foundation Medicine's FoundationOne T5 assay, which sequences 313 cancer-related genes. Kozono and colleagues analyzed Lung-MAP data from 1,672 patients with squamous cell lung cancer and compared it with squamous lung cancer data from The Cancer Genome Atlas. A primary goal: spot novel pairs of genetic alterations in squamous cell lung cancers. These pairs are important because they provide clues about how mutations may contribute to the growth and spread of cancer - information that can be used to create more effective cancer drugs. In the Lung-MAP data, the team uncovered a set of three genes that have never before appeared together - PARP4, NFE2L2, and KEAP1. These findings suggest that all three genes may affect how lung cells respond to oxidative stress, and how treatment resistance may form, and, for the first time, suggest that PARP4 may play role in this key biological pathway. "With novel pairs of mutations, it's 'guilt by association,'" Kozono says. "When you find these, they can hold a real clue about what a gene does. And when you know what a gene does, you have a better understanding of how it might affect responses to a drug. Kozono presents this work January 31 (Abstract MA11.10).

Philip Mack, PhD (Tisch Cancer Institute, Mount Sinai) will give a mini-oral presentation on the feasibility of using plasma circulating tumor DNA (ctDNA) to detect key cancer mutations that can be used to guide therapy in lung cancer, such as alterations in the BRAF, RET, EGFR, KRAS and MET genes. In Lung-MAP, patients who submitted fresh tissue samples for genetic screening also provided plasma samples to measure ctDNA, an approach to cancer detection, characterization, and monitoring known as a "liquid biopsy." Mack and colleagues studied paired samples of both tissue and plasma from 129 Lung-MAP patients. Of those, 52 had critical driver mutations detected in their tissue biopsy samples. The analysis showed that 43 patients also had the same drivers detected in plasma - for an 83 percent sensitivity rate. Of the 77 patients with no drivers detected in their tissue, two patients had drivers detected in ctDNA - for a 97 percent specificity rate. While the ctDNA results were impressive, Mack said they don't yet support a plasma-only approach to genetic screening. While ctDNA testing is faster, cheaper, and much less invasive for patients, tissue samples are still the genetic screening gold standard. Mack said the results do support the use of ctDNA if patients can't - or won't - undergo a second tumor biopsy. "This would speed enrollment onto the trial, and spare patients time, money, and a painful procedure," Mack said. "That's good news." Mack delivers his presentation January 30 (Abstract MA08.10).

To see the full abstracts for these and all WCLC presentations, visit the conference website.

Lung-MAP is a groundbreaking public-private partnership, one that includes the NCI and its National Clinical Trials Network (NCTN) including SWOG Cancer Research Network, Friends of Cancer Research, the Foundation for the National Institutes of Health (FNIH), Foundation Medicine, pharmaceutical companies which provided their drugs for the study, and several lung cancer advocacy organizations.

Since the trial is offered at more than 700 U.S. medical centers and community hospitals under the NCTN and the NCI Community Oncology Research Program (NCORP), Lung-MAP makes it easier for patients to receive investigational treatments to fight their non-small cell lung cancer. Lung-MAP is more flexible, and faster, than traditional clinical trial models. Where typical trials require the development of individual studies for each new drug tested, Lung-MAP uses a single "master protocol," which is amended as drugs enter and exit the trial, preserving infrastructure and patient outreach efforts. This makes Lung-MAP more efficient and cost-effective, allowing researchers to quickly answer the critical question: Does this new drug work?

Since its launch, Lung-MAP has registered more than 3,660 patients. Lung-MAP leaders have worked with 10 pharmaceutical partners, in coordination with the FNIH, to launch 13 studies, 12 of which are completed. The trial is addressing questions about the efficacy of immunotherapies and immunotherapy combinations and the validity of new biomarkers. The trial has also produced critical insights into the conduct of large-scale precision medicine trials, including tissue sampling and banking, genetic screening, and patient communication.

Credit: 
SWOG

A mild way to upcycle plastics used in bottles into fuel and other high-value products

Plastic is ubiquitous in people's lives. Yet, when plastic-containing items have fulfilled their missions, only a small amount is recycled into new products, which are often of lower quality compared to the original material. And, transforming this waste into high-value chemicals requires substantial energy. Now, researchers reporting in ACS' JACS Au have combined a ruthenium-carbon catalyst and mild, lower-energy reaction conditions to convert plastics used in bottles and other packaging into fuels and chemical feedstock.

Global production of sturdy, single-use plastic for toys, sterile medical packaging, and food and beverage containers is increasing. Polyolefin polymers, such as polyethylene and polypropylene, are the most common plastics used in these products because the polymers' molecular structures -- long, straight chains of carbon and hydrogen atoms -- make materials very durable. It's difficult to degrade the carbon-to-carbon bonds in polyolefins, however, so energy-intensive procedures using high temperatures, from 800 to 1400 F, or strong chemicals are needed to break down and recycle them. Previous studies have shown that noble metals, such as zirconium, platinum and ruthenium, can catalyze the process of splitting apart short, simple hydrocarbon chains and complicated, plant-based lignin molecules at moderate reaction temperatures requiring less energy than other techniques. So, Yuriy Román-Leshkov and colleagues wanted to see if metal-based catalysts would have a similar effect on solid polyolefins with long hydrocarbon chains, disintegrating them into usable chemicals and natural gas.

The researchers developed a method to react simple hydrocarbon chains with hydrogen in the presence of noble- or transition-metal nanoparticles under mild conditions. In their experiments, ruthenium-carbon nanoparticles converted over 90% of the hydrocarbons into shorter compounds at 392 F. Then, the team tested the new method on more complex polyolefins, including a commercially available plastic bottle. Despite not pretreating the samples, as is necessary with current energy-intensive methods, they were completely broken down into gaseous and liquid products using this new method. In contrast to current degradation methods, the reaction could be tuned so that it yielded either natural gas or a combination of natural gas and liquid alkanes. The researchers say implementing their method could help reduce the volume of post-consumer waste in landfills by recycling plastics to desirable, highly valuable alkanes, though technology to purify the products is needed to make the process economically feasible.

Credit: 
American Chemical Society

New Tel Aviv University study reveals 'Achilles' heel' of cancer cells

What makes cancer cells different from ordinary cells in our bodies? Can these differences be used to strike at them and paralyze their activity? Cancer researchers have been debating this question since the mid-19th century.

A new study from Tel Aviv University (TAU) shows, for the first time, how an abnormal number of chromosomes (aneuploidy) -- a unique characteristic of cancer cells that researchers have known about for decades -- could become a weak point for these cells. The study could lead to the development of future drugs that will use this vulnerability to eliminate the cancer cells.

The study was conducted in the laboratory of Dr. Uri Ben-David of TAU's Sackler Faculty of Medicine, in collaboration with six laboratories from four other countries. It was published in the journal Nature on January 27, 2021.

Aneuploidy is a hallmark of cancer. Normal human cells contain two sets of 23 chromosomes each, one from the father and one from the mother. But aneuploid cells have a different number of chromosomes. When aneuploidy forms in cancer cells, the cells not only "tolerate" it, but it can even advance the progression of the disease. The relationship between aneuploidy and cancer was discovered over a century ago, long before it was known that cancer was a genetic disease and even before the discovery of DNA as hereditary material.

According to Dr. Ben-David, aneuploidy is the most common genetic change in cancer. Approximately 90% of solid tumors, such as breast cancer and colon cancer, and 75% of blood cancers are aneuploid in nature. But researchers' understanding of the how aneuploidy contributes to the development and spread of cancer has been limited.

In the study, the researchers used advanced bioinformatics methods to quantify aneuploidy in approximately 1,000 cancer cell cultures. They then compared the genetic dependency and drug sensitivity of the cells with a high level of aneuploidy to those of the cells with a low level of aneuploidy.

They found that aneuploid cancer cells demonstrate heightened sensitivity to damage to the mitotic checkpoint - a cellular checkpoint that ensures the proper separation of chromosomes during cell division. They also discovered the molecular basis for the heightened sensitivity of aneuploid cancer cells.

The study has important implications for the drug discovery process in personalized cancer medicine. Drugs that delay the separation of chromosomes are undergoing clinical trials, but it is not known which patients will respond to them and which will not. The results of this study suggest that it will be possible to use aneuploidy as a biological marker to identify patients who will respond better to these drugs.

"It should be emphasized that the study was done on cells in a culture and not on cancer patients. In order to translate it to treatment of cancer patients, many more follow-up studies must be performed. Still, even at this stage it is clear that the study could have a number of medical implications," Dr. Ben-David says.

Credit: 
American Friends of Tel Aviv University

First ever 'pioneer' factor found in plants enables cells to change their fate

image: Using an experimental technique whereby flowers can be coaxed to form from plant roots, biologists led by the University of Pennsylvania's Doris Wagner uncovered a protein that enables for the initial loosening of chromatin that can allow new proteins to be made and plants to take on different forms.

Image: 
University of Pennsylvania

Cells don't express all the genes they contain all the time. The portion of our genome that encodes eye color, for example, doesn't need to be turned on in liver cells. In plants, genes encoding the structure of a flower can be turned off in cells that will form a leaf.

These unneeded genes are kept from becoming active by being stowed in dense chromatin, a tightly packed bundle of genetic material laced with proteins.

In a new study in the journal Nature Communications, biologists from the University of Pennsylvania identify a protein that enables plant cells to reach these otherwise inaccessible genes in order to switch between different identities. Called a "pioneer transcription factor," the LEAFY protein gets a foothold in particular portions of the chromatin bundle, loosening the structure and recruiting other proteins that eventually allow genes to first be transcribed into RNA and then translated into proteins.

"The programs that are not needed in a given cell or tissue or condition are effectively shut off by various chromatin modifications that make them very inaccessible," says biologist Doris Wagner of the School of Arts & Sciences, senior author on the work. "The question has always been, How do you go from shut to open? We found that LEAFY, this protein that we already knew was important in reprogramming plant cells, is one of these pioneer transcription factors that get a foot in the door, as it were, to alter the program of cells."

Pioneer transcription factors were first characterized by Penn faculty member Kenneth Zaret of the Perelman School of Medicine, whose own work has examined these regulatory proteins in animals, such as in the context of liver development. Early in her time at Penn, Wagner heard Zaret give a talk about his work in this area and grew curious about looking for similar factors in plants, given that flexible gene expression is so critical to their survival.

Indeed, plants must switch between expressing whole sets of different genes all the time. In rich soils, they may grow more branches to get bigger, while in a drought they may express more genes associated with developing flowers, so they can set seed and reproduce before they succumb.

How plant cells determine their identity and fate has been a focus of Wagner's work since the start of her career, and so has LEAFY. During her postdoc days, Wagner showed that LEAFY could reprogram root cells to produce flowers. "That gave us a good clue that LEAFY might have this 'pioneer' activity, but we had to look more closely to prove it," she says.

To do so, Wagner and colleagues first used isolated protein and strands of genetic material to show that LEAFY, though not other transcription factors, bound to nucleosomes, subunits of chromatin where DNA spools on a cluster of proteins called histones. Specifically, the binding occurred at the gene AP1, which is known to be activated by LEAFY to prompt plants to make flowers.

To confirm that this connection was true in a living organism, the researchers took plant roots and applied a compound that causes them to flower spontaneously. When flowering, they found that not only did LEAFY bind strongly to AP1 but that the binding site was also occupied by a histone. "This tells us that the histones and LEAFY are really occupying the same portion of DNA," Wagner says.

Furthermore, they showed that chromatin structure began to open up at the AP1 region when LEAFY was activated, a key facet of what pioneer transcription factors do. This opening was limited, and full loosening of chromatin took days. What did happen quickly, the researchers found, was that LEAFY displaced a linker histone protein, creating a small local opening that also allowed other transcription factors to nose their way into the DNA.

Though pioneer transcription factors had been proposed to exist in plants, the new work provides the first concrete support backing this conception for LEAFY. And Wagner believes there are others. "If necessary, plants can alter their entire body plan or generate an entire plant from a little piece of leaf," she says. "We predict setting this in motion will require pioneer transcription factors. So plants may actually have more of these factors than animals."

In upcoming work, she and her team hope to delve more deeply into the processes that precede and follow this "pioneering" activity of LEAFY: Does anything restrict its activity and how do the other factors that it recruits fully unpack the hidden-away genes? "It would be great to find out both sides of this equation," Wagner says.

The findings have significance in agriculture and breeding, where LEAFY is already manipulated to encourage earlier flowering, for example. And as more is understood about pioneer transcription factors in plants, Wagner can envision a fine tuning of other aspects of plant growth and activity, which could be leveraged to help crops adapt to new environmental conditions, such as those being ushered in by climate change.

Credit: 
University of Pennsylvania

Fields of breeders' dreams: A team effort toward targeted crop improvements

image: Harvesting switchgrass in Texas under field rainout shelters for drought tolerance studies. This image complements a Nature paper announcing the release of a high-quality reference sequence of the complex switchgrass genome. The work was led by researchers at the University of Texas (UT) at Austin, the HudsonAlpha Institute for Biotechnology (HudsonAlpha), and the U.S. Department of Energy (DOE) Joint Genome Institute (JGI), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory (Berkeley Lab).

Image: 
David Lowry

Gardeners and farmers around the country recognize that crop varieties grow best in certain regions. Most plant species have adapted to their local environments; for example, crop and ornamental seeds sold for the upper Midwest are often very different than those bred for Texas. Identifying and breeding varieties that have high productivity across a range of environments is becoming increasingly important for food, fuel and other applications, and breeders aren't interested in waiting decades to develop new crops.

One example is an ongoing collaborative effort to improve the emerging bioenergy crop switchgrass (Panicum virgatum), which has established 10 experimental gardens located in eight states spread across 1,100 miles. Switchgrass is a perennial grass that quickly grows in a variety of soils and water conditions, standing taller than basketball star LeBron James. In each garden, switchgrass plants clonally propagated from cuttings represent a diverse collection sourced from half of the United States.

As reported January 27, 2021 in Nature, the team led by researchers at the University of Texas (UT) at Austin, the HudsonAlpha Institute for Biotechnology (HudsonAlpha), and the U.S. Department of Energy (DOE) Joint Genome Institute (JGI), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory (Berkeley Lab), has produced a high-quality reference sequence of the complex switchgrass genome using samples collected at these gardens. Building off this work, researchers at all four DOE Bioenergy Research Centers (BRCs)--the Great Lakes Bioenergy Research Center (GLBRC), the Center for Bioenergy Innovation, the Center for Advanced Bioenergy & Bioproducts Institute, and the Joint BioEnergy Institute--have expanded the network of common gardens and are exploring improvements to switchgrass through more targeted genome editing techniques to customize the crop for additional end products.

The genetic diversity within this set of plants, each with a fully-sequenced genome, and these gardens allow researchers to test what genes affect the plant's adaptability to various environmental conditions. "To accelerate breeding for bioenergy, we need to make connections between the plant's traits and genetic diversity," said John Lovell, an evolutionary biologist at HudsonAlpha and first author of the study. "For that, it's necessary to have the plant's genome as a reference. Additionally, having the gardens as a resource helps breeders find genetic regions of interest." The combination of field data and genetic information has allowed the research team to associate climate adaptations with switchgrass biology, information that could be useful toward the DOE's interest in harnessing the crop as a versatile candidate biomass feedstock for producing sustainable alternative fuels.

Common Gardens Are A Community Effort

The common gardens began nearly a decade ago with a proposal from UT-Austin's Tom Juenger, a longtime JGI collaborator and a senior author on this study. The use of switchgrass as a feedstock for biomass-based fuels was initially fostered by DOE's Bioenergy Research Centers, which initiated the sequencing of the switchgrass genome. DOE's Billion Ton Report, identified potential switchgrass production areas across the U.S., guiding the location of the common gardens. "Gardeners and farmers fully understand that when you move plants outside of their native habitat or cold hardiness zones, they have different levels of performance," Juenger said. "The novelty here is that we're trying to actually figure out what's causing those differences rather than just observing them. Can we quantify them? Can we tie them to the genome? We can use common garden plantings of clonally propagated plants to address these questions."

Multiple collection methods were applied to gather the diversity of switchgrass plants represented in the gardens. "Tom gave me a truck and I drove all over Texas with a shovel," recalled study co-author David Lowry, who started as a postdoctoral fellow in the Juenger lab and continues to work on the project from a lab at Michigan State University that is affiliated with the GLBRC. Additional samples came from U.S. Department of Agriculture stock centers, collaborators, and collections at other field sites. "This paper is a combination of really cutting-edge genomics and genetic analysis with large scale data collection," he added.

Jeremy Schmutz, head of the JGI Plant Program, drew parallels between these common gardens and those previously grown for the DOE candidate feedstock poplar. "You're collecting natural diversity and you're planting natural diversity in multiple locations, and then you are extracting links between the genetic variation and phenotypic performance," he said. Both switchgrass and poplar are JGI Flagship Plants.

Reaping Long-Term Investment Benefits

Switchgrass has a large polyploid genome, which means most genes are found as multiple copies across the chromosomes. "In the past, we needed model systems to test genetic hypotheses in species with large and complex genomes," said Lovell. "However, new sequencing technologies have allowed us to build the necessary genome resources to directly test for genes involved in biomass yield and climate adaptation in switchgrass, despite its physical size and genome complexity."

Work on the switchgrass genome sequence started more than a decade ago. As sequencing technologies have advanced, assembly and annotation of the genome sequence has improved in parallel. For example, the current version of the genome is assembled into sequences of 5.5 million basepair (bp) in length, while the previous version had an average of 25,000 bp pieces. That's the difference between assembling a 10,000-piece puzzle and doing the same puzzle with just 50 pieces.

The combination of new genetic tools and experimental gardens allow researchers to detect climate-gene matches, which can be exploited for accelerated crop improvement. "Because of the DOE's long-term investment and the effort that has gone into this, people are going to be able to model further research on this complex species and also at the same time, take advantage of what we can do now with genomics to really make inroads into plant biology and improvements of switchgrass as the crop species," Schmutz said.

The switchgrass genotypes that were planted into the common gardens were sequenced and assembled by the JGI, allowing the research team to conduct association mapping, linking genes to traits. One of the team's findings is that the performance of switchgrass across the garden sites depended on the origin or collection location of the individual switchgrass plants. They were able to identify many regions in the switchgrass genome that are associated with genetic differences that lead to productivity in different environments.

For example, many plants collected from native habitats in Texas and other southern locales did not survive the cold winter of 2019 at the most northern common garden in South Dakota. Conversely, upper Midwest native switchgrass plants performed poorly at the southern common gardens in Texas. This reciprocal home site advantage is direct evidence of climatic adaptation. The team's database of genes that underlie adaptation to climate provides breeders with a strong foundation to improve crop productivity under specific climates.

Sourcing plants from so many parts of the country also helped the team understand why some switchgrass plants from the Northeast have traits similar to those from the Midwest, even though their genomes were very different.

The high quality reference genome sequence of switchgrass is available on the JGI plant data portal Phytozome. This version can help breeders identify genomic regions of interest and directly introduce these features into new crop varieties. "It's going to be important to have all this information in order to facilitate breeding going forward," noted Lowry.

The team has received additional DOE funding to continue maintaining the gardens, which excites Juenger. "There will be a continuation of collecting data and information from these existing plantings, and then trying to leverage these discoveries to better understand how plants tolerate stresses and challenges in the natural environment," he said. "There aren't many efforts that have been able to study native perennial plants with these genetic and genomic resources, interweaved with this long longitudinal study perspective. Although it's been this enormous investment to set up these gardens, we have them to study for a number of years. And that's a real benefit for the research program."

Credit: 
DOE/Lawrence Berkeley National Laboratory

Focusing on field analysis

image: Integration of polymeric membrane/dielectric sphere assemblies in microfluidic chips for enhanced-contrast imaging with low-magnification systems, doi 10.1117/1.JOM.1.1.014001.

Image: 
Viri et al.

The development of cost-efficient, portable microscopy units would greatly expand their use in remote field locations and in places with fewer resources, potentially leading to easier on-site analysis of contaminants such as E. coli in water sources as well as other practical applications.

Current microscopy systems, like those used to image micro-organisms, are expensive because they are optimized for maximum resolution and minimal deformation of the images the systems produce. But some situations do not require such optimization--for instance, simply detecting the presence of pathogens in water. One potential approach to developing a low-cost portable microscopy system is to use transparent microspheres in combination with affordable low-magnification objective lenses to increase image resolution and sensitivity.

A group of researchers from Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland published a study on such an assembly composed of barium titanate spheres that are partially embedded in thin polymeric membranes. The result of their work, appearing in SPIE's new Journal of Optical Microsystems, is a proposed method to fabricate microfluidic chips using the assembly for enhanced detection of bacteria. Such customized chips with fluidic and optical components already integrated have many benefits when combined with portable low-end imagers for analyses at remote sites or in resource-limited regions.

"Cost reduction and portability are of benefit to the proliferation of analytical devices, especially in limited-resource contexts, and the integration of affordable micro-optical elements directly onto microfluidic chips can highly contribute to this," said Martin Gijs, a professor at EPFL and an author of the published work.

The assembly's ability to enhance bacteria detection paves the way for other applications friendly to use at remote sites. Additionally, the researchers revealed an opportunity to customize specific functional microfluidic elements. Such integrations could bring to fruition applications such as on-site antibiotic testing.

Given falling costs of the components and fabrication methods, the researchers' proposed fabrication protocol could be adapted easily for a wide variety of microfluidic chips with integrated optical elements. Considered along with the lower cost of low-end imaging systems, the approach could sharply increase the use of such microscopy systems in low-resource locations for on-site analyses.

Credit: 
SPIE--International Society for Optics and Photonics

Purported phosphine on Venus more likely to be ordinary sulfur dioxide, new study shows

image: An image of Venus compiled using data from the Mariner 10 spacecraft in 1974.

URL: https://solarsystem.nasa.gov/resources/2524/newly-processed-views-of-ven...

Image: 
NASA/JPL-Caltech

In September, a team led by astronomers in the United Kingdom announced that they had detected the chemical phosphine in the thick clouds of Venus. The team's reported detection, based on observations by two Earth-based radio telescopes, surprised many Venus experts. Earth's atmosphere contains small amounts of phosphine, which may be produced by life. Phosphine on Venus generated buzz that the planet, often succinctly touted as a "hellscape," could somehow harbor life within its acidic clouds.

Since that initial claim, other science teams have cast doubt on the reliability of the phosphine detection. Now, a team led by researchers at the University of Washington has used a robust model of the conditions within the atmosphere of Venus to revisit and comprehensively reinterpret the radio telescope observations underlying the initial phosphine claim. As they report in a paper accepted to the Astrophysical Journal and posted Jan. 25 to the preprint site arXiv, the U.K.-led group likely wasn't detecting phosphine at all.

"Instead of phosphine in the clouds of Venus, the data are consistent with an alternative hypothesis: They were detecting sulfur dioxide," said co-author Victoria Meadows, a UW professor of astronomy. "Sulfur dioxide is the third-most-common chemical compound in Venus' atmosphere, and it is not considered a sign of life."

The team behind the new study also includes scientists at NASA's Caltech-based Jet Propulsion Laboratory, the NASA Goddard Space Flight Center, the Georgia Institute of Technology, the NASA Ames Research Center and the University of California, Riverside.

The UW-led team shows that sulfur dioxide, at levels plausible for Venus, can not only explain the observations but is also more consistent with what astronomers know of the planet's atmosphere and its punishing chemical environment, which includes clouds of sulfuric acid. In addition, the researchers show that the initial signal originated not in the planet's cloud layer, but far above it, in an upper layer of Venus' atmosphere where phosphine molecules would be destroyed within seconds. This lends more support to the hypothesis that sulfur dioxide produced the signal.

Both the purported phosphine signal and this new interpretation of the data center on radio astronomy. Every chemical compound absorbs unique wavelengths of the electromagnetic spectrum, which includes radio waves, X-rays and visible light. Astronomers use radio waves, light and other emissions from planets to learn about their chemical composition, among other properties.

In 2017 using the James Clerk Maxwell Telescope, or JCMT, the U.K.-led team discovered a feature in the radio emissions from Venus at 266.94 gigahertz. Both phosphine and sulfur dioxide absorb radio waves near that frequency. To differentiate between the two, in 2019 the same team obtained follow-up observations of Venus using the Atacama Large Millimeter/submillimeter Array, or ALMA. Their analysis of ALMA observations at frequencies where only sulfur dioxide absorbs led the team to conclude that sulfur dioxide levels in Venus were too low to account for the signal at 266.94 gigahertz, and that it must instead be coming from phosphine.

In this new study by the UW-led group, the researchers started by modeling conditions within Venus' atmosphere, and using that as a basis to comprehensively interpret the features that were seen -- and not seen -- in the JCMT and ALMA datasets.

"This is what's known as a radiative transfer model, and it incorporates data from several decades' worth of observations of Venus from multiple sources, including observatories here on Earth and spacecraft missions like Venus Express," said lead author Andrew Lincowski, a researcher with the UW Department of Astronomy.

The team used that model to simulate signals from phosphine and sulfur dioxide for different levels of Venus' atmosphere, and how those signals would be picked up by the JCMT and ALMA in their 2017 and 2019 configurations. Based on the shape of the 266.94-gigahertz signal picked up by the JCMT, the absorption was not coming from Venus' cloud layer, the team reports. Instead, most of the observed signal originated some 50 or more miles above the surface, in Venus' mesosphere. At that altitude, harsh chemicals and ultraviolet radiation would shred phosphine molecules within seconds.

"Phosphine in the mesosphere is even more fragile than phosphine in Venus' clouds," said Meadows. "If the JCMT signal were from phosphine in the mesosphere, then to account for the strength of the signal and the compound's sub-second lifetime at that altitude, phosphine would have to be delivered to the mesosphere at about 100 times the rate that oxygen is pumped into Earth's atmosphere by photosynthesis."

The researchers also discovered that the ALMA data likely significantly underestimated the amount of sulfur dioxide in Venus' atmosphere, an observation that the U.K.-led team had used to assert that the bulk of the 266.94-gigahertz signal was from phosphine.

"The antenna configuration of ALMA at the time of the 2019 observations has an undesirable side effect: The signals from gases that can be found nearly everywhere in Venus' atmosphere -- like sulfur dioxide -- give off weaker signals than gases distributed over a smaller scale," said co-author Alex Akins, a researcher at the Jet Propulsion Laboratory.

This phenomenon, known as spectral line dilution, would not have affected the JCMT observations, leading to an underestimate of how much sulfur dioxide was being seen by JCMT.

"They inferred a low detection of sulfur dioxide because of that artificially weak signal from ALMA," said Lincowski. "But our modeling suggests that the line-diluted ALMA data would have still been consistent with typical or even large amounts of Venus sulfur dioxide, which could fully explain the observed JCMT signal."

"When this new discovery was announced, the reported low sulfur dioxide abundance was at odds with what we already know about Venus and its clouds," said Meadows. "Our new work provides a complete framework that shows how typical amounts of sulfur dioxide in the Venus mesosphere can explain both the signal detections, and non-detections, in the JCMT and ALMA data, without the need for phosphine."

With science teams around the world following up with fresh observations of Earth's cloud-shrouded neighbor, this new study provides an alternative explanation to the claim that something geologically, chemically or biologically must be generating phosphine in the clouds. But though this signal appears to have a more straightforward explanation -- with a toxic atmosphere, bone-crushing pressure and some of our solar system's hottest temperatures outside of the sun -- Venus remains a world of mysteries, with much left for us to explore.

Credit: 
University of Washington

Melatonin produced in the lungs prevents infection by novel coronavirus

image: The hormone acts as a barrier against SARS-CoV-2, blocking the expression of genes that encode proteins in cells serving as viral entry points, according to a study by researchers at the University of São Paulo

Image: 
NIAD/NIH

By Elton Alisson  |  Agência FAPESP – Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2, preventing expression of genes that encode proteins in cells such as resident macrophages in the nose and pulmonary alveoli, and epithelial cells lining the alveoli, all of which are entry points for the virus. The hormone, therefore, prevents infection of these cells by the virus and inhibits the immune response so that the virus remains in the respiratory tract for a few days, eventually leaving to find another host.

The discovery by researchers at the University of São Paulo (USP), in Brazil, helps understand why some people are not infected or do not manifest symptoms of COVID-19 even when reliably diagnosed as carriers of the virus by RT-PCR. In addition, it offers the prospect of nasal administration of melatonin, in drops or as a spray, to prevent disease from developing in pre-symptomatic patients. 

Pre-clinical and clinical trials will be needed to prove the therapeutic efficacy of melatonin against the virus, the researchers stress in an article on the study published in the journal Melatonin Research. 

The study was supported by FAPESP.

“We showed that melatonin produced in the lung acts as a barrier against SARS-CoV-2, preventing the virus from entering the epithelium, activating the immune system and triggering the production of antibodies,” Regina Pekelmann Markus, a professor at USP’s Institute of Biosciences (IB) and principal investigator for the project, told Agência FAPESP.

“This action mechanism by pulmonary melatonin must also involve other respiratory viruses such as influenza,” she added.

Markus began researching melatonin in the 1990s. In a study involving rodents, she showed that the hormone, produced at night by the pineal gland in the brain to tell the organism daylight has gone and it should prepare for sleep, can be produced in other organs, such as the lungs.

In a study also involving rodents, published in early 2020 in the Journal of Pineal Research, Markus and collaborators showed that resident macrophages in the pulmonary airspace absorb (phagocytize) particles of pollution. This aggressive stimulus induced the production of melatonin and other molecules by the macrophages, engulfing the particulate matter in the air breathed in by the animals and stimulating mucous formation, coughing, and expectoration to expel the particles from the respiratory tract.

When they blocked melatonin synthesis by resident macrophages, the researchers observed that the particles entered the bloodstream and spread throughout the organism, even invading the brain.

Based on the finding that melatonin produced in the lungs altered the entry points for particulate matter from air pollution, Markus and collaborators decided to investigate whether the hormone performed the same function with regard to SARS-CoV-2. “If so, the virus wouldn’t be able to bind to the ACE-2 receptor on cells, enter the epithelium and infect the organism,” Markus said.

Analysis of gene expression

To test this hypothesis, the researchers analyzed 455 genes associated in the literature with COVID-19 comorbidities, interaction between SARS-CoV-2 and human proteins, and viral entry points. The genes had been identified in studies conducted, among others, by Helder Nakaya, a professor at USP’s School of Pharmaceutical Sciences (FCF) and a co-author of the study on lung melatonin. 

From this group of genes, they selected 212 genes involved in viral cell entry, intracellular traffic, mitochondrial activity, and transcription and post-translation processes, to create a physiological signature of COVID-19.

Using RNA sequencing data downloaded from a public database, they quantified the level of expression of the 212 COVID-19 signature genes in 288 samples from healthy human lungs.

They then correlated these gene expression levels with a gene index that estimated the capacity of the lungs to synthesize melatonin (MEL-Index), based on their analysis of the lungs in healthy rodents. They found that the lower the index the higher the level of expression of genes that encode proteins for resident macrophages and epithelial cells.

The index also correlated negatively with genes that modify proteins in cell receptor CD147, a viral entry point in macrophages and other immune cells, indicating that normal lung melatonin production may be a natural protector against the virus.

The results were corroborated by three statistical techniques: the Pearson test, which measures the degree of linear correlation between two variables; a gene set enrichment analysis; and a network analysis tool that maps the connections among the most expressed genes so as to compare the same set of genes in different states. The latter was developed by Marcos Buckeridge, a professor at IB-USP and also a co-author of the study.

“We found that when MEL-Index was high the entry points for the virus in the lungs were closed, and when it was low these ‘doors’ were open. When the doors are shut, the virus wanders around for a time in the pulmonary airspace and then tries to escape in search of another host,” Markus said.

Because lung melatonin inhibits transcription of these genes that encode proteins for viral entry point cells, application of melatonin directly into the lungs in the form of drops or spray could block the virus. More research is required to prove that this is indeed the case, however, the researchers note. 

Another idea could be to use MEL-Index, the pulmonary melatonin metric, as a prognostic biomarker to detect asymptomatic carriers of SARS-CoV-2.

Credit: 
Fundação de Amparo à Pesquisa do Estado de São Paulo

Study reveals precarious employment on the rise long before COVID-19

A study led by a University of Illinois Chicago researcher uses a new approach to measure precarious, or low-quality, employment in the United States. And, according to those findings, precarious employment has increased 9% between 1988 and 2016.

Precarious employment, or P.E., is defined as low-quality employment, which is often characterized by low wages, job insecurity and irregular hours, making employment risky and stressful for the worker.

In her study, "Changes in precarious employment in the United States: A longitudinal analysis," Vanessa Oddo, assistant professor in UIC's School of Applied Health Sciences, sought to create a multidimensional and continuous measure of P.E. in the U.S. She also set out to describe changes in precarious employment over time, both overall and within subgroups. The paper is published in the Scandinavian Journal of Work, Environment & Health.

A better understanding of long-term trends is a critical first step for informing future policies aimed at improving P.E. and population health in the U.S., Oddo said.

Previously, the focus for measuring P.E. was on wages, hours and union membership. For this longitudinal study, she expanded the measurement criteria to add P.E. indicators including:

Material rewards -- the wage and non-wage benefits afforded by employment.

Working-time arrangements -- the length and intensity of working hours, underemployment and schedule predictability.

Employment stability -- employment continuity, contractual temporariness and/or organizational changes (e.g., downsizing).

Workers' rights -- describes welfare state provisions associated with employment, such as access to health insurance or pensions.

Collective organization -- the possibilities (or lack thereof) for employee representation, most commonly measured through union representation.

Interpersonal relations -- employees' power relative to management (e.g., their ability to make decisions or control their schedule) and can include exposure to discrimination.

Training opportunities -- opportunities for promotion or to enhance skills.

Characterizing trends in P.E. using a multidimensional indicator is critical given that employment quality is increasingly recognized as a social determinant of health, according to Oddo.

P.E. can result in insufficient income, which compromises access to food and other necessities; greater exposure to adverse physical working conditions, such as toxic exposure, and limited control over both personal and professional lives, leading to stress.

"Importantly, poor employment quality may be contributing to widening health inequities, as women, people with lower education levels, and minorities have a higher prevalence of P.E.," Oddo said.

The research revealed P.E. score was significantly higher among people of color, women, people with lower levels of education and people with lower income. Between 1988 and 2016, the overall P.E. scores significantly increased indicating worsening employment quality over time.

However, the study showed the largest increases in P.E. among males, people with a college education, and higher-income individuals.

"These results suggest long-term decreases in employment quality are widespread in the U.S., rather than just confined to marginalized segments of the labor market," Oddo said.

According to the study, the largest change over time in employment precarity among males and college-educated and higher-income individuals could be because their P.E. score was lower at the study's beginning in 1988, leaving a greater opportunity for declines. Additionally, the large increase in P.E. among males may also be due to the declining rate of union membership in the U.S., as union membership is associated with better employment quality and, historically, was more common among males.

Oddo said P.E. has been studied more broadly after the 2008 recession when employment quality worsened and there was a notable shift toward contract work and the emergence of the gig economy. She added that there is speculation as to how the COVID-19 pandemic will affect P.E., both during the pandemic and after when work from home measures are lifted.

A holistic approach to studying P.E. is important in the future as data can inform employment policy decisions. For example, a better understanding of P.E. in the U.S. may be helpful for informing future policies around secure scheduling (i.e. advanced notice of schedules) or gig work, like California's Assembly Bill 5, which changed the rules employers must use to determine whether workers are employees or independent. The distinction is important because independent contractors are not entitled to?most of the protections and benefits?that employees get, Oddo explained.

Also, precarious employment could slow our ability to get back to work after COVID-19, as precariously employed individuals could face additional barriers to COVID-19 vaccination; for example, if they are undocumented workers or independent contractors.

Credit: 
University of Illinois Chicago

New report charts path toward superior earthquake recovery

For the last century, seismic building codes and practices have primarily focused on saving lives by reducing the likelihood of significant damage or structural collapse. Recovery of critical functions provided by buildings and infrastructure have received less attention, however. As a result, many remain vulnerable to being knocked out of service by an earthquake for months, years or for good.

A committee of experts, formed by the National Institute of Standards and Technology (NIST) and the Federal Emergency Management Agency (FEMA) under the direction of Congress, has urged officials at all levels of government to support research and policies that could help get the buildings and services society depends on up and running quickly after an earthquake. In a report delivered to Congress, the committee outlines seven recommendations that, if acted upon, may greatly improve the resilience of communities across the nation.

"As structural engineers we feel confident that the current building codes can deliver life safety design objectives. Now, it's time to go beyond that and think about recovery of function," said Siamak Sattar, a NIST structural engineer and co-author of the report.

In 2011, a magnitude 6.3 earthquake struck Christchurch, New Zealand. Over 180 lives were lost as a result, but many more were likely saved by modern building codes. However, the city's economy and quality of life were not spared.

The quake damaged the city's central business district to the point that hundreds of buildings were closed or demolished, displacing thousands of workers. Lifeline infrastructure systems -- including power, clean water and roads -- sustained heavy damage, further crippling the community's ability to bounce back. In total, the estimated costs of rebuilding the city amounted to 40 billion New Zealand dollars ($26.6 billion).

The toll taken by the Christchurch earthquake and other damaging events can in part be attributed to limitations in seismic codes and standards, as most offer little guidance on designing buildings or lifelines to recover in a timely manner in the wake of extreme events.

To prevent major earthquakes from leaving such lasting impressions in the future, Congress entrusted NIST and FEMA -- both member agencies of the National Earthquake Hazards Reduction Program (NEHRP), which NIST leads -- with the responsibility of mapping a path to greater community resilience.

Drawing expertise from both public and private sectors, NIST and FEMA assembled a committee of more than 30 engineers, architects, building owners, code officials and social scientists -- including several of their own researchers -- to devise options for addressing gaps in codes, standards and practices, which are described in their report to Congress.

The first recommendation summarizes the core of the report. The authors call for members of the government, codes and standards organizations and industry to work together in developing a national framework for setting and achieving goals based on recovery time. To produce this framework, experts must first identify what level of function provided by buildings and lifelines should be maintained after an earthquake, and then determine an acceptable time for them to be out of commission.

"There are different metrics that we can use to help guide this framework. For example, a building may need to recover within a predefined number of days, weeks or months. If it is a hospital or emergency center then you may not want it to go down at all," said Steve McCabe, director of NEHRP.

The authors also highlight the need for new recovery-based design criteria for buildings and lifelines. If developed with recovery in mind, these criteria could steer design parameters -- such as increasing a school's structural strength to limit damage or designing an electrical power supply to return to service faster -- toward improving community resilience. A critical phase of this process would be identifying the level of ground shaking that designs should be tailored to for recovery goals, which may vary by region.

Other recommendations seek to help leaders meet recovery goals aligned with the first recommendation, offering guidance on implementing new design requirements for buildings and lifelines. They also provide direction for pre-disaster planning -- a key step in preparing authorities to make timely decisions in the immediate aftermath of a disaster.

The authors seek to empower communities as well by recommending the launch of an education campaign on earthquake risk and recovery, which could reach the public through social media, streaming services or other media.

"Informed citizens are an important resource needed to develop the kind of vision required for this effort, which may well represent the largest change in building codes in 75 years," McCabe said.

In the report, the authors encourage officials to consider adopting functional recovery approaches that go beyond the current requirements. They assert that the initial investments of adopting new recovery-focused codes and upgrading older buildings and lifelines could likely be offset by the reduction of future losses. They also suggest that increased access to financial resources through mechanisms such as grant programs, incentive systems and public financing would help local governments scale the upfront costs.

"The immediate aim of the report is to spark a national conversation about developing a consensus for recovery goals and timelines. This approach may eventually be reflected in building codes, but first, a considerable amount of research must be tackled," Sattar said.

New policies could make use of the NEHRP agencies, such as NIST and FEMA, whose expertise may enable them to provide the necessary science for sound public policy.

The road toward this goal could take years to traverse, but it is critical.

In the meantime, the authors encourage early action by leaders at state and local levels, as each community may have needs that national guidelines cannot fully address. Their experiences with functional recovery planning and design could also make for valuable feedback at the national level, speeding up progress toward widespread earthquake resilience that preserves quality of life in addition to life itself.

Credit: 
National Institute of Standards and Technology (NIST)